Timing and Clinical Features of Spontaneous Decrease in Size of Small Pancreatic Cystic Lesions without High-Risk Stigmata
0
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background/Aims: The natural history of spontaneous decrease in the size of pancreatic cystic lesions (PCLs) without high-risk stigmata is under investigation. This study aimed to investigate the timing of spontaneous decrease in the size of PCLs without high-risk stigmata and to identify the characteristics associated with their complete resolution. Methods: From 2000 to 2016, patients with spontaneous decreases in PCL size on computed tomography (CT) and/or magnetic resonance imaging (MRI) who had at least 1 year of follow-up were evaluated retrospectively. Results: A total of 78 patients underwent follow-up for an average of 55.7 months. Most patients were asymptomatic, and 35 (37.2%) showed complete resolution. The initial mean PCL size was 1.6±0.9 cm (range, 0.5 to 5.6 cm). The average time to initial decrease in size and complete resolution of PCLs were 32.1 and 41.5 months, respectively. Compared with PCLs that completely resolved, presence of underlying malignancy was associated with partial resolution of PCLs in multivariable analysis (hazard ratio, 0.51; 95% confidence interval, 0.32 to 0.81; p=0.005). Endoscopic ultrasound (EUS) identified detailed findings, especially the presence of septum (p<0.001), calcification (p=0.015) and lobulation (p=0.001) that were not found on CT/MRI. Conclusions: Asymptomatic small PCLs without high-risk stigmata can naturally decrease in size at approximately 3 years, and complete resolution can be expected in the absence of underlying malignancy. Regular follow-up of approximately 3 years with EUS may be a reasonable and safe alternative when planning the initial treatment of small PCLs without high-risk stigmata.
Abstract
Background/Aims: The natural history of spontaneous decrease in the size of pancreatic cystic lesions (PCLs) without high-risk stigmata is under investigation. This study aimed to investigate the timing of spontaneous decrease in the size of PCLs without high-risk stigmata and to identify the characteristics associated with their complete resolution. Methods: From 2000 to 2016, patients with spontaneous decreases in PCL size on computed tomography (CT) and/or magnetic resonance imaging (MRI) who had at least 1 year of follow-up were evaluated retrospectively. Results: A total of 78 patients underwent follow-up for an average of 55.7 months. Most patients were asymptomatic, and 35 (37.2%) showed complete resolution. The initial mean PCL size was 1.6±0.9 cm (range, 0.5 to 5.6 cm). The average time to initial decrease in size and complete resolution of PCLs were 32.1 and 41.5 months, respectively. Compared with PCLs that completely resolved, presence of underlying malignancy was associated with partial resolution of PCLs in multivariable analysis (hazard ratio, 0.51; 95% confidence interval, 0.32 to 0.81; p=0.005). Endoscopic ultrasound (EUS) identified detailed findings, especially the presence of septum (p<0.001), calcification (p=0.015) and lobulation (p=0.001) that were not found on CT/MRI. Conclusions: Asymptomatic small PCLs without high-risk stigmata can naturally decrease in size at approximately 3 years, and complete resolution can be expected in the absence of underlying malignancy. Regular follow-up of approximately 3 years with EUS may be a reasonable and safe alternative when planning the initial treatment of small PCLs without high-risk stigmata.
참고문헌 (21)
- Laffan TA, "Prevalence of unsuspected pancreatic cysts on MDCT", AJR Am J Roentgenol, 191, pp.802~807 (2008)
- de Jong K, "Disappointing interobserver agreement among radiologists for a classifying diagnosis of pancreatic cysts using magnetic resonance imaging", Pancreas, 41, pp.278~282 (2012)
- Vege SS, "American gastroenterological association institute guideline on the diagnosis and management of asymptomatic neoplastic pancreatic cysts", Gastroenterology, 148, pp.819~822 (2015)
- Lee KS, "Prevalence of incidental pancreatic cysts in the adult population on MR imaging", Am J Gastroenterol, 105, pp.2079~2084 (2010)
- Tanaka M, "International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas", Pancreatology, 12, pp.183~197 (2012)
- Tanaka M, "International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas", Pancreatology, 6, pp.17~32 (2006)
- Aranha GV, "The nature and course of cystic pancreatic lesions diagnosed by ultrasound", Arch Surg, 118, pp.486~488 (1983)
- Brook OR, "Delayed growth in incidental pancreatic cysts: are the current American college of radiology recommendations for follow-up appropriate?", Radiology, 278, pp.752~761 (2016)
- Handrich SJ, "The natural history of the incidentally discovered small simple pancreatic cyst : longterm follow-up and clinical implications", AJR Am J Roentgenol, 184, pp.20~23 (2005)
- Tsai HM, "Features associated with progression of small pancreatic cystic lesions : a retrospective study", World J Gastroenterol, 21, pp.13309~13315 (2015)
- Sahani DV, "Cystic pancreatic lesions : a simple imagingbased classification system for guiding management", Radiographics, 25, pp.1471~1484 (2005)
- Lu X, "The diagnostic value of EUS in pancreatic cystic neoplasms compared with CT and MRI", Endosc Ultrasound, 4, pp.324~329 (2015)
- Wilcox CM, "Editorial : management of the small asymptomatic pancreatic cyst : somehow along the way we forgot about the patient", Am J Gastroenterol, 112, pp.1337~1339 (2017)
- Patel NC, "Association of intraductal papillary mucinous neoplasm(IPMN)with extra-pancreatic cystic lesions : is there a systemic cystic disorder", Am J Gastroenterol, 107, pp.1265~1266 (2012)
- Sey MS, "Prospective cross-sectional study of the prevalence of incidental pancreatic cysts during routine outpatient endoscopic ultrasound", Pancreas, 44, pp.1130~1133 (2015)
- Cadili A, "Survival in cystic neoplasms of the pancreas", Can J Gastroenterol, 23, pp.537~542 (2009)
- Sato Y, "Intraductal papillary-mucinous neoplasm of the pancreas associated with polycystic liver and kidney disease", Pathol Int, 59, pp.201~204 (2009)
- Ishikawa T, "Prevalence of pancreatic cystic lesions including intraductal papillary mucinous neoplasms in patients with end-stage renal disease on hemodialysis", Pancreas, 38, pp.175~179 (2009)
- Benarroch-Gampel J, "Extrapancreatic malignancies and intraductal papillary mucinous neoplasms of the pancreas", World J Gastrointest Surg, 2, pp.363~367 (2010)
- Larghi A, "Prevalence and risk factors of extrapancreatic malignancies in a large cohort of patients with intraductal papillary mucinous neoplasm(IPMN)of the pancreas", Ann Oncol, 24, pp.1907~1911 (2013)
- Reid-Lombardo KM, "Frequency of extrapancreatic neoplasms in intraductal papillary mucinous neoplasm of the pancreas : implications for management", Ann Surg, 251, pp.64~69 (2010)